# Specification Quality Checklist: Evidence Model & Synthetic Taint

**Purpose**: Validate specification completeness and quality before proceeding to planning
**Created**: 2026-06-18
**Feature**: [spec.md](../spec.md)

## Content Quality

- [x] No implementation details (languages, frameworks, APIs)
- [x] Focused on user value and business needs
- [x] Written for non-technical stakeholders
- [x] All mandatory sections completed

## Requirement Completeness

- [x] No [NEEDS CLARIFICATION] markers remain
- [x] Requirements are testable and unambiguous
- [x] Success criteria are measurable
- [x] Success criteria are technology-agnostic (no implementation details)
- [x] All acceptance scenarios are defined
- [x] Edge cases are identified
- [x] Scope is clearly bounded
- [x] Dependencies and assumptions identified

## Feature Readiness

- [x] All functional requirements have clear acceptance criteria
- [x] User scenarios cover primary flows
- [x] Feature meets measurable outcomes defined in Success Criteria
- [x] No implementation details leak into specification

## Notes

- The `EvidenceState` case names (*Pending* / *Real* / *Synthetic* / *Failed* /
  *Skipped* / *AutoSynthetic*) appear in the spec because they are the **domain
  vocabulary** of the evidence model itself (mirrored from the governance-design
  kernel doc), not implementation choices — the same way F04's spec named
  `Deterministic` / `AgentReviewed` / `HumanOnly`. The *representation* (how the
  graph, node identity, and `effective` are typed) is deliberately left to the
  plan and `.fsi`.
- Zero [NEEDS CLARIFICATION] markers: the F05 roadmap entry and the
  governance-design kernel doc fix the surface (`EvidenceState`, `EvidenceGraph`,
  `effective` closure) and the taint semantics precisely, so all gaps were closed
  with documented assumptions rather than open questions.
- All checklist items pass on the first validation pass — spec is ready for
  `/speckit-clarify` (optional) or `/speckit-plan`.
